Type:
Educational Exhibit
Keywords:
Performed at one institution, Diagnostic or prognostic study, Prospective, Metastases, Cancer, Diagnostic procedure, Comparative studies, PET-CT, Thyroid / Parathyroids, Hybrid Imaging, Hybrid, Molecular and Translational Imaging
Authors:
A. A. M. M. S. khalifa1, S. M. I. Y. Shalaby2, M. Ali1, A. Mostafa1, A. Ibrahim1, A. Yassin3; 1Cairo/EG, 2Cairo, Ca/EG, 3cairo, cairo/EG
DOI:
10.26044/ecr2020/C-07318
References
1- Lin F & Iagaru A( 2016): Updates on PET/CT & thyroid cancer Radiology, 28:8-12.
2- Bertagna F, Biasiotto G, Orlando E et al. (2017): Role of F-18 FDG PET/CT in patients affected by differentiated thyroid cancer with high thyroglobulin level & negative I-131 scan. Japn J Radiol., 28: 629- 636.
3- Hamed M, Abdelghany A ,Osman A( 2014):The diagnostic usefulness of FDG-PET/CT in detecting tumor recurrence not evident in whole body I131 scan in differentiated thyroid carcinoma.The Egyptian journal of radiology & nuclear medina, 25: 361–364.
4- Razfar A, Barton F, Steven P, et al. (2015): Clinical usefulness of PET/CT in recurrent Thyroid carcinoma .Otolaryngology Head and Neck surgery;136:120-125.
5- Mosci A, Camila S& Iagaru A. (2013): Role of PET/CT in recurrent thyroid cance (2011).Clinical Nuclear Medicine; 136:120-125.
6- Kim S, Lee TH, Kim IJ, et al. (2016): Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients having negative Iodine WBS & elevated serum thyroglobulin. European Journal of radiology; 70: 17-24.
7-Aygun N. (2012): Imaging of recurrent thyroid carcinoma Otolaryngologic clinics of North America;41: 1095-1106.
8-Leboulleux S, Pamela R & Schlumberger M.(2014): Role of PET/CT in follow up patients treated from differentiated thyroid cancer. Clinical Nuclear Medicine;3:112-121.
9-Muresan M, Olivier P & Leclere J. (2008 ):Role of PET/CT in detection of metastatic Thyroid cancer. European Journal of Radiology ;15:37-49.